Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

This content is available also in other languages


This content is available also in other languages

Latest innovations.

Our expertise.

Life Sciences

Advance research and accelerate clinical impact with our reagents, automation solutions and applications expertise.


Scale clinical diagnostic solutions with our reagents, automation and deep regulatory expertise.


Expedite your healthcare innovation and gain a competitive edge with our OEM services and solutions.

Customer stories.​

Novel methods guiding cancer treatment

The UK company, The Binding Site, partnered with Tecan to automate their innovative multiple myeloma diagnostic method, providing more accurate results and faster access for patients.

Post-mortem RNA sequencing revolutionizes neurological research

Tecan's Trio RNA-Seq kit aids Cerevance in studying neurodegenerative disorders, offering high sensitivity for enhanced disease understanding and drug discovery.

State-of-the-art assays for myasthenia gravis

Tecan offers a gold-standard test for Myasthenia Gravis, aiding in early diagnosis and treatment to improve patients' quality of life and health outcomes. Their highly specific biomarkers and targeted assays are instrumental in this effort.

The latest Tecan News and Events